<?xml version="1.0" encoding="UTF-8"?>
<fig id="vaccines-07-00070-f002" orientation="portrait" position="float">
 <label>Figure 2</label>
 <caption>
  <p>Analysis of the gH/gL/gO-PDGFRα complex. Size exclusion chromatography profile of the gH/gL/gO alone (
   <bold>a</bold>), or complexed with PDGFRα (
   <bold>b</bold>), or PDGFRα and the Fab fragment of the anti-gH mAb 13H11 (
   <bold>c</bold>). The shift in the elution time of (
   <bold>b</bold>) and (
   <bold>c</bold>) complexes compared to (
   <bold>a</bold>) is indicated by vertical dotted lines. (d) SDS-PAGE in reducing conditions of individual proteins and complexes, as indicated. (
   <bold>e</bold>–
   <bold>g</bold>) EM negative staining of gH/gL/gO alone (
   <bold>e</bold>), complexed with PDGFRα (indicated by a red dotted line) bound to gO (
   <bold>f</bold>), and with PDGFRα (indicated by a red dotted line) and the Fab of mAb anti-gH 13H11 (indicated by a yellow dotted line) bound to the twisted region of gH (
   <bold>g</bold>). (
   <bold>h</bold>) EM 3D map of gH/gL/gO at 19.3 Å resolution (from [
   <xref rid="B68-vaccines-07-00070" ref-type="bibr">68</xref>]).
  </p>
 </caption>
 <graphic xlink:href="vaccines-07-00070-g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
